Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Uridine supplementation with Mitocnol antagonizes antiretroviral nucleoside analogue-induced mitochondrial peripheral and cerebral neuropathy in vivo ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1-2 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1-2, 12.2008
- Creator
-
Lebrecht, D.
- Contributor
-
Deveaud, C.
Beauvoit, B.
Bonnet, J.
Kirschner, J.
Mueller, K.
Venhoff, N.
Walker, UA
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P148
- URN
-
urn:nbn:de:1111-2016052054541
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lebrecht, D.
- Deveaud, C.
- Beauvoit, B.
- Bonnet, J.
- Kirschner, J.
- Mueller, K.
- Venhoff, N.
- Walker, UA
- SpringerLink (Online service)
Other Objects (12)
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue
Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations
Synthese carbocyclischer Nucleoside
Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue
Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations
Synthese carbocyclischer Nucleoside
Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue
Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue
Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations
Synthese carbocyclischer Nucleoside
Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression